Cargando…

Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires

BACKGROUND: Anabolic-androgenic steroids (AAS) are used to increase muscle strength and improve appearance, but users also carry the risk of developing physical and mental health problems. In Norway, the substance use disorder treatment system provides health care to this patient group, but few AAS...

Descripción completa

Detalles Bibliográficos
Autores principales: Havnes, Ingrid Amalia, Jørstad, Marie Lindvik, Wisløff, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524231/
https://www.ncbi.nlm.nih.gov/pubmed/31096999
http://dx.doi.org/10.1186/s13011-019-0206-5
_version_ 1783419514503823360
author Havnes, Ingrid Amalia
Jørstad, Marie Lindvik
Wisløff, Christine
author_facet Havnes, Ingrid Amalia
Jørstad, Marie Lindvik
Wisløff, Christine
author_sort Havnes, Ingrid Amalia
collection PubMed
description BACKGROUND: Anabolic-androgenic steroids (AAS) are used to increase muscle strength and improve appearance, but users also carry the risk of developing physical and mental health problems. In Norway, the substance use disorder treatment system provides health care to this patient group, but few AAS users have sought such treatment. Therefore, a service was created to inform AAS users and next of kin of potential negative consequences and their treatment options. This study describes health problems, motivations for AAS cessation, and treatment desires among AAS users. METHODS: Over four years, 232 AAS users and 60 next of kin contacted the information service and received an hour-long information session with healthcare personnel. Information about AAS use, physical and mental health problems, substance use, motivation for cessation, and whether the information seeker desired treatment were registered. Qualitative interviews were conducted among seven individuals and analyzed thematically to explore information service experiences. RESULTS: Of the 232 AAS users, 179 (77.2%) desired treatment after completing the information session and 53 (22.9%) were unsure or did not want treatment. Those who desired treatment were significantly older, had used AAS longer, reported more physical and mental health side effects, and a higher proportion reported having children than those who did not desire treatment. Although 181 (78.0%) reported co-occuring physical and mental health problems, mental health problems were the most common motivation for AAS cessation (n = 108, 47.8%), followed by a combination of mental and physical health problems (52, 23.0%). Findings from qualitative interviews suggest that barriers to treatment may be overcome with an easily accessible service that informs about addiction treatment and facilitates the treatment entry process. CONCLUSIONS: Healthcare professionals who encounter users of AAS should have knowledge about AAS use and adverse effects. The desire for health care reveals extensive health problems and the user group is so non-homogeneous that examination and treatment must be adapted individually with focus on physical, mental and social factors as well as possible dependence of AAS and/or psychoactive substances.
format Online
Article
Text
id pubmed-6524231
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65242312019-05-24 Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires Havnes, Ingrid Amalia Jørstad, Marie Lindvik Wisløff, Christine Subst Abuse Treat Prev Policy Research BACKGROUND: Anabolic-androgenic steroids (AAS) are used to increase muscle strength and improve appearance, but users also carry the risk of developing physical and mental health problems. In Norway, the substance use disorder treatment system provides health care to this patient group, but few AAS users have sought such treatment. Therefore, a service was created to inform AAS users and next of kin of potential negative consequences and their treatment options. This study describes health problems, motivations for AAS cessation, and treatment desires among AAS users. METHODS: Over four years, 232 AAS users and 60 next of kin contacted the information service and received an hour-long information session with healthcare personnel. Information about AAS use, physical and mental health problems, substance use, motivation for cessation, and whether the information seeker desired treatment were registered. Qualitative interviews were conducted among seven individuals and analyzed thematically to explore information service experiences. RESULTS: Of the 232 AAS users, 179 (77.2%) desired treatment after completing the information session and 53 (22.9%) were unsure or did not want treatment. Those who desired treatment were significantly older, had used AAS longer, reported more physical and mental health side effects, and a higher proportion reported having children than those who did not desire treatment. Although 181 (78.0%) reported co-occuring physical and mental health problems, mental health problems were the most common motivation for AAS cessation (n = 108, 47.8%), followed by a combination of mental and physical health problems (52, 23.0%). Findings from qualitative interviews suggest that barriers to treatment may be overcome with an easily accessible service that informs about addiction treatment and facilitates the treatment entry process. CONCLUSIONS: Healthcare professionals who encounter users of AAS should have knowledge about AAS use and adverse effects. The desire for health care reveals extensive health problems and the user group is so non-homogeneous that examination and treatment must be adapted individually with focus on physical, mental and social factors as well as possible dependence of AAS and/or psychoactive substances. BioMed Central 2019-05-16 /pmc/articles/PMC6524231/ /pubmed/31096999 http://dx.doi.org/10.1186/s13011-019-0206-5 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Havnes, Ingrid Amalia
Jørstad, Marie Lindvik
Wisløff, Christine
Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires
title Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires
title_full Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires
title_fullStr Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires
title_full_unstemmed Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires
title_short Anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires
title_sort anabolic-androgenic steroid users receiving health-related information; health problems, motivations to quit and treatment desires
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524231/
https://www.ncbi.nlm.nih.gov/pubmed/31096999
http://dx.doi.org/10.1186/s13011-019-0206-5
work_keys_str_mv AT havnesingridamalia anabolicandrogenicsteroidusersreceivinghealthrelatedinformationhealthproblemsmotivationstoquitandtreatmentdesires
AT jørstadmarielindvik anabolicandrogenicsteroidusersreceivinghealthrelatedinformationhealthproblemsmotivationstoquitandtreatmentdesires
AT wisløffchristine anabolicandrogenicsteroidusersreceivinghealthrelatedinformationhealthproblemsmotivationstoquitandtreatmentdesires